Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON37817Active, not recruiting
Randomised, open-label trial of lacosamide and warfarin in epilepsy (2 arms), sponsored by UCB. Primary endpoints: Warfarin pharmacokinetics and Warfarin pharmacodynamics. Started Jan 2012; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON37817.